Study on smoked Cannabis underway in Canada

Study on smoked Cannabis underway in Canada
Sources: Canadian Broadcasting Corporation of 22 December
2003, CNN Newswire of 26 July 2001

After 2½ years of delay, a study on the benefits of cannabis as a pain reliever is underway in Montreal. Dr. Mark Ware, a professor of family medicine and anesthesia at McGill University is heading the study. He wants to determine the therapeutic value of cannabis in neuropathic pain under real-life conditions and to find out the best dose. 32 patients will be enrolled. They smoke a pipe, now licensed as a medical device. Patients will receive different strengths of cannabis at home in a random order and report their experiences.

In July 2001 Health Minister Allan Rock announced that the government will fund the study, but Health Canada blocked the study, since there was no accepted supplier of cannabis. The department has now given permission to a supplier to release its product for the trial. Early results are expected in early 2005.

HempPharm.com comment; how can one wait 2½ years (?), while people are dying and in pain, this is unacceptable in a civilized society, thank you Ann McLellan for your 'logic' 'common sense' 'compassion' and stupidity!

*Industrial-Hemp has no psychoactive properties following definition of the European Economic Community (EEC); THC content is less than 0.3%. In general, low THC-seed varieties without psychoactive properties are those that have a THC content of less than 1%. (See also No-THC Hemp-seed.) THC= Delta-9 TetraHydroCannabinol.